H.R. 4913 · 116th Congress
To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under…
Full title
To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
McKinleySponsor21 cosponsors · 12 D, 9 R
D
Kuster
PO
R
Olson
PW
D
Welch
TB
R
Budd
DJ
R
Joyce
DS
D
Soto
PT
D
Tonko
KB
D
Bass
BC
R
Carter
AC
D
Craig
SC
D
Carbajal
GR
R
Reschenthaler
DM
D
Matsui
BR
D
Rush
RR
D
Ruiz
AG
R
Gonzalez
JG
D
Garamendi
AM
R
Mooney
LG
R
Gooden
CM
R
McMorris Rodgers
BL
D
Lawrence1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill establishes additional requirements for prescription drug plan (PDP) sponsors that use formularies under the Medicare prescription drug benefit.
What it does: CRS summary · Introduced in House · Oct 30, 2019
This bill establishes additional requirements for prescription drug plan (PDP) sponsors that use formularies under the Medicare prescription drug benefit.
Specifically, the bill requires PDP formularies to include covered generic drugs and biosimilars for which the wholesale acquisition cost is less than that of the reference (i.e., brand-name) product. PDP sponsors must also establish specific cost-sharing tiers that apply lower cost-sharing requirements for such covered generic drugs and biosimilars as compared to those for brand-name products.
The bill also prohibits PDP sponsors from instituting certain requirements relating to access to such covered generic drugs and biosimilars that are more restrictive than those for brand-name products (e.g., prior authorization requirements).
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes.
Latest action (Oct 30, 2019): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Oct 30, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.